These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


127 related items for PubMed ID: 38811046

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Airway Mucus Hyperconcentration in Non-Cystic Fibrosis Bronchiectasis.
    Ramsey KA, Chen ACH, Radicioni G, Lourie R, Martin M, Broomfield A, Sheng YH, Hasnain SZ, Radford-Smith G, Simms LA, Burr L, Thornton DJ, Bowler SD, Livengood S, Ceppe A, Knowles MR, Noone PG, Donaldson SH, Hill DB, Ehre C, Button B, Alexis NE, Kesimer M, Boucher RC, McGuckin MA.
    Am J Respir Crit Care Med; 2020 Mar 15; 201(6):661-670. PubMed ID: 31765597
    [Abstract] [Full Text] [Related]

  • 4. A novel microbiota stratification system predicts future exacerbations in bronchiectasis.
    Rogers GB, Zain NM, Bruce KD, Burr LD, Chen AC, Rivett DW, McGuckin MA, Serisier DJ.
    Ann Am Thorac Soc; 2014 May 15; 11(4):496-503. PubMed ID: 24592925
    [Abstract] [Full Text] [Related]

  • 5. The role of non-invasive modalities for assessing inflammation in patients with non-cystic fibrosis bronchiectasis.
    Tsikrika S, Dimakou K, Papaioannou AI, Hillas G, Thanos L, Kostikas K, Loukides S, Papiris S, Koulouris N, Bakakos P.
    Cytokine; 2017 Nov 15; 99():281-286. PubMed ID: 28863927
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Aggregatibacter is inversely associated with inflammatory mediators in sputa of patients with chronic airway diseases and reduces inflammation in vitro.
    Goeteyn E, Taylor SL, Dicker A, Bollé L, Wauters M, Joossens M, Van Braeckel E, Simpson JL, Burr L, Chalmers JD, Rogers GB, Crabbé A.
    Respir Res; 2024 Oct 12; 25(1):368. PubMed ID: 39395980
    [Abstract] [Full Text] [Related]

  • 8. Role of cilia, mucus, and airway surface liquid in mucociliary dysfunction: lessons from mouse models.
    Mall MA.
    J Aerosol Med Pulm Drug Deliv; 2008 Mar 12; 21(1):13-24. PubMed ID: 18518828
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Effect of osmolality on mucociliary transportability and rheology of cystic fibrosis and bronchiectasis sputum.
    Shibuya Y, Wills PJ, Cole PJ.
    Respirology; 2003 Jun 12; 8(2):181-5. PubMed ID: 12753533
    [Abstract] [Full Text] [Related]

  • 14. The clinical impacts of lung microbiome in bronchiectasis with fixed airflow obstruction: a prospective cohort study.
    Chen YF, Hou HH, Chien N, Lu KZ, Lin CH, Liao YC, Lor KL, Chien JY, Chen CM, Chen CY, Cheng SL, Wang HC, Hsueh PR, Yu CJ.
    Respir Res; 2024 Aug 14; 25(1):308. PubMed ID: 39143556
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The effect of erythromycin on mucociliary transportability and rheology of cystic fibrosis and bronchiectasis sputum.
    Shibuya Y, Wills PJ, Cole PJ.
    Respiration; 2001 Aug 14; 68(6):615-9. PubMed ID: 11786718
    [Abstract] [Full Text] [Related]

  • 19. A point-of-care neutrophil elastase activity assay identifies bronchiectasis severity, airway infection and risk of exacerbation.
    Shoemark A, Cant E, Carreto L, Smith A, Oriano M, Keir HR, Perea L, Canto E, Terranova L, Vidal S, Moffitt K, Aliberti S, Sibila O, Chalmers JD.
    Eur Respir J; 2019 Jun 14; 53(6):. PubMed ID: 31151955
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.